tiprankstipranks
Trending News
More News >
Evgen Pharma (GB:TCF)
:TCF
UK Market

Evgen Pharma (TCF) Technical Analysis

Compare
1 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
5Neutral
9Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Evgen Pharma’s (TCF) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Evgen Pharma is a Sell.
Evgen Pharma’s (TCF) 20-Day exponential moving average is 0.24, while Evgen Pharma’s (TCF) share price is 0.24p, making it a Buy.
Evgen Pharma’s (TCF) 50-Day exponential moving average is 0.28, while Evgen Pharma’s (TCF) share price is 0.24p, making it a Sell.

Evgen Pharma (TCF) Pivot Points

May 21, 2025, 05:43 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.23
0.23
0.24
0.24
0.24
0.24
0.24
Fibonacci
0.23
0.23
0.24
0.24
0.24
0.24
0.24
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Evgen Pharma (TCF) Moving Averages

May 21, 2025, 05:43 PM
Period
Simple
Exponential
MA5
0.24Sell
0.24Buy
MA10
0.24Sell
0.24Buy
MA20
0.23Buy
0.24Buy
MA50
0.22Buy
0.28Sell
MA100
0.48Sell
0.39Sell
MA200
0.56Sell
0.52Sell
Evgen Pharma’s (TCF) 10-Day exponential moving average is 0.24, while Evgen Pharma’s (TCF) share price is 0.24p, making it a Buy.
Evgen Pharma’s (TCF) 100-Day exponential moving average is 0.39, while Evgen Pharma’s (TCF) share price is 0.24p, making it a Sell.
Evgen Pharma’s (TCF) stock price is 0.24p and Evgen Pharma’s (TCF) 50-day simple moving average is 0.22, creating a Buy signal.
Evgen Pharma’s (TCF) stock price is 0.24p and Evgen Pharma’s (TCF) 100-day simple moving average is 0.48, creating a Sell signal.
Evgen Pharma’s (TCF) stock price is 0.24p and Evgen Pharma’s (TCF) 200-day simple moving average is 0.56, creating a Sell signal.

Evgen Pharma (TCF) Technical Indicators

May 21, 2025, 05:43 PM
Name
Value
Implied Action
RSI (14)
50.73
Neutral
STOCH (9,6)
57.14
Neutral
STOCHRSI (14)
57.14
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
15.80
Buy
Williams %R
-42.86
Buy
CCI (14)
-2.51
Neutral
ATR (14)
0.03
-
Ultimate Oscillator
50.25
Neutral
ROC
9.09
Buy
Evgen Pharma’s (TCF) Relative Strength Index (RSI) is 50.73, creating a Neutral signal.
Evgen Pharma’s (TCF) Trend Strength Indicator (ADX) is 15.80, creating a Buy signal.
Evgen Pharma’s (TCF) Commodity Channel Index (CCI) is -2.51, creating a Neutral signal.
Evgen Pharma’s (TCF) Price Rate of Change (ROC) is 9.09, creating a Buy signal.

FAQ

Is TCF a Buy, Hold, or Sell?
Based on TCF’s technical indicators, TCF is a Hold.
    What is TCF’s RSI (14)?
    TCF’s RSI (14) is 50.73, which suggests TCF is a Neutral.
      What is TCF’s MACD?
      TCF’s MACD is >-0.01, which suggests TCF is a Sell.
        What is TCF’s 5-day moving average?
        TCF’s 5-day moving average is 0.24, which suggests TCF is a Sell.
          What is TCF’s 20-day moving average?
          TCF 20-day moving average is 0.23, which suggests TCF is a Buy.
            What is TCF’s 50-day moving average?
            TCF’s 50-day moving average is 0.22, which suggests TCF is a Buy.
              What is TCF’s 200-day moving average?
              TCF’s 200-day moving average is 0.56, which suggests TCF is a Sell.
                What is TCF’s Williams % R (14)?
                TCF’s Williams % R (14) is -42.86, which suggests TCF is a Buy.
                  What is TCF’s CCI (14)?
                  TCF’s CCI (14) is -2.51, which suggests TCF is a Neutral.
                    What is the share price of Evgen Pharma?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis